Press Releases

Relevium Issues Statement Regarding Recent Promotional Activity

MONTREAL, July 01, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent...

read more

Relevium Closes Private Placement Financing

MONTREAL, June 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of 15,350,000...

read more

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis and...

read more

Albertus P. Engelbrecht Files Early Warning Report

May 21, 2019 (TheNewswire.ca) -- (via TheNewswire) MONTREAL, QUEBEC / TheNewswire / May 21, 2019 - Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the "Shareholder") announces the filing of an early warning...

read more

Relevium Announces Private Share Purchase by CEO

MONTREAL, May 21, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that Mr. Aurelio Useche, Chief Executive Officer, has agreed to purchase a total of 4,213,713 common...

read more